Determine the necessary mass, volume, or concentration for preparing a solution.
This is a demo store. No orders will be fulfilled.
| SKU | Size | Availability |
Price | Qty |
|---|---|---|---|---|
|
Ab182948-100μg
|
100μg |
10
|
$69.90
|
|
|
Ab182948-1mg
|
1mg |
4
|
$349.90
|
|
|
Ab182948-5mg
|
5mg |
1
|
$909.90
|
|
|
Ab182948-10mg
|
10mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$1,459.90
|
|
Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
| Product Name | Socazolimab (anti-PD-L1) - Primary antibody, specific to CD274, >95% (SDS-PAGE&SEC), high purity, Human IgG1, INHIBITOR of Programmed cell death 1 ligand 1 inhibitor |
|---|---|
| Synonyms | B7 H antibody | B7 H1 antibody | B7 homolog 1 antibody | B7-H1 antibody | B7H antibody | B7H1 antibody | CD 274 antibody | CD-274 antibody | CD274 antibody | CD274 antigen antibody | CD274 molecule antibody | MGC142294 antibody | MGC142296 antibody | OTTH |
| Specifications & Purity | Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA |
| Host species | Human |
| Specificity | CD274 |
| Conjugation | Unconjugated |
| Grade | Animal Free, Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated |
| Action Type | INHIBITOR |
| Mechanism of action | INHIBITOR of Programmed cell death 1 ligand 1 inhibitor |
| Product Description |
Socazolimab (anti-PD-L1) is an anti-PD-L1 monoclonal antibody. Socazolimab (anti-PD-L1) has lasting safety and efficacy in the treatment of recurrent or metastatic cervical cancer. Socazolimab (anti-PD-L1) also has potential applications in small cell lung cancer, esophageal squamous cell carcinoma (ESCC), advanced urothelial carcinoma and osteosarcoma. Purity >95% (SDS-PAGE&SEC) Endotoxin Level < 1.0EU/mg |
| Isotype | Human IgG1 |
|---|---|
| Light Chain Type | lambda |
| SDS-PAGE | 28.0 kDa (Light Chain) & 52.0 kDa (Heavy Chain), under reducing conditions; 207.2 kDa, under non-reducing conditions. |
| Purification Method | Protein A purified |
| Purity | >95% (SDS-PAGE&SEC) |
| Shape | Liquid |
| Concentration | See COA |
| Storage Temp | Store at -80°C,Avoid repeated freezing and thawing |
| Shipped In | Ice chest + Ice pads |
| Stability And Storage | Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle. |
| CAS | 2305043-30-3 |
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Socazolimab (anti-PD-L1) (Ab182948) - Flow Cytometry
Flow Cytometry analysis of Jurkat cells labelling PD-L1 (red) with Socazolimab (anti-PD-L1) (Ab182948). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Socazolimab (anti-PD-L1) (Ab182948) - ELISA
Immobilized Recombinant Human PD-L1 protein (rp169666) at 1.0 μg/mL can bind Socazolimab (anti-PD-L1) (Ab182948) with the EC50 of 97.84 ng/mL.
Socazolimab (anti-PD-L1) (Ab182948) - SEC
The purity of Socazolimab (anti-PD-L1) (Ab182948) is more than 95% verified by HPLC.
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
| Certificate of Analysis | Jun 19, 2024 | Ab182948 | |
| Certificate of Analysis | Jun 19, 2024 | Ab182948 | |
| Certificate of Analysis | Jun 19, 2024 | Ab182948 |
Starting at $109.90
Starting at $89.90
Starting at $109.90
Starting at $69.90
Starting at $109.90
Starting at $34.90
Starting at $79.90
Starting at $79.90
Starting at $16.90
Starting at $49.90
Starting at $99.90
Starting at $109.90
Starting at $109.90
Starting at $66.90